Multiple EULAR presentations reinforce potential of AlloNK to drive deep B-cell depletion and meaningful clinical responses across refractory ...

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.

Rheumatoid arthritis-associated interstitial lung disease (ILD) presents a paradox: it is common and a major cause of ...

Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare.

According to researchers at Semmelweis University, not only inflammation, but also sleep disorders, depression, obesity, and ...

Strong initial responses in 4 of 6 patients after many standard drugs had failed ...

Conditions like depression may not only be complications of this rheumatoid arthritis, but may also be involved in the ...

Whether you are seeking information for yourself or a loved one, read on to learn more about the disease and how to better understand its signs and symptoms. Rheumatoid arthritis is an inflammatory ...

RA can affect more than your joints—here are the symptoms doctors say are often overlooked.

On February 2, 2024, the voices of many people who have rheumatoid disease will be heard. Rheumatoid disease, also known as rheumatoid arthritis (RA), is an autoimmune condition in which the body ...

Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...

There is good news for patients with rheumatoid arthritis. Research from Aarhus University and Aarhus University Hospital may have opened the door to an entirely new way of reducing inflammation in ...